Neurosurgery Partnerships Identify and engage high-volume neuro-oncology and epilepsy centers to adopt NeuroBlate MR-guided LITT as a minimally invasive alternative with shorter hospital stays and lower complication rates. Leverage the multi-center clinical evidence to build a compelling ROI case for neurosurgical departments, tumor boards, and hospital procurement teams.

Robotics Synergy Opportunities Capitalize on the Symphony Robotics integration by pursuing co-sale opportunities with robotics platforms and academic centers piloting robotic brain surgery. Position NB3 FullFire as a robotic-compatible energy delivery solution to expand the addressable market within neurosurgery and improve procedure precision.

Financing-Driven Growth Leverage recent growth financing to accelerate deployment and training programs. Offer flexible financing terms, bundled service agreements, and funded pilots in target hospitals to reduce procurement friction and speed adoption among health systems pursuing capital efficiency.

Market Diversification Expand market reach into radiation oncology and epilepsy care by cross-selling to centers treating brain tumors, metastases, necrosis, and drug-resistant epilepsy. Emphasize the unique MR-guided ablation capability and potential to complement or substitute for traditional radiotherapy and open surgery in select cases.

Evidence and Champions Build an evidence- and KOL-driven sales model to establish Monteris as a technology leader in minimally invasive brain surgery. Develop reference centers and clinical outcomes case studies to support purchasing decisions and accelerate expansion into new geographies and specialties.